Fact Check: The FDA announced on April 15th that in July they will consider legalizing seven peptides by moving ...

Claim: The FDA announced on April 15th that in July they will consider legalizing seven peptides by moving them from category 2 to category 1.

Verdict: Correct (95% confidence)

Explanation: According to RAPS, the FDA announced that its advisory committee would review seven peptides in July, considering their reclassification from category 2 to category 1 (RAPS). BioPharma Dive confirms that the FDA is scheduling advisory committee meetings to discuss easing restrictions on peptides (BioPharma Dive). The Washington Post also reports that the FDA is taking steps toward potentially easing access to certain peptides, aligning with the claim's timeline and intent (Washington Post). Thes...